Article Information
History
- October 18, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Hayley A. McNamara1,
- Azza H. Idris2,
- Henry J. Sutton1,
- Barbara J. Flynn2,
- Yeping Cai1,
- Kevin Wiehe3,4,
- Kirsten E. Lyke5,
- Deepyan Chatterjee1,
- Natasha KC6,
- Sumana Chakravarty6,
- B. Kim Lee Sim6,
- Stephen L. Hoffman5,
- Mattia Bonsignori3,4,
- Robert A. Seder2 and
- Ian A. Cockburn1,*
- 1Department of Immunology and Infectious Disease, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, 2601, Australia
- 2Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
- 3Duke Human Vaccine Institute, Durham, NC 27710, USA
- 4Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
- 5Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD 21201, USA
- 6Sanaria Inc., Rockville, MD 20850, USA
- ↵*Corresponding author, email: ian.cockburn{at}anu.edu.au tel: +61 2 6125 4619